Connection

Terry Day to Sirolimus

Back to Details
This is a "connection" page, showing publications Terry Day has written about Sirolimus.
Terry Day
Connection Strength
1.145
Sirolimus
  1. Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clin Cancer Res. 2019 02 15; 25(4):1156-1164.
    View in: PubMed
    Score: 0.604
  2. mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma. Curr Treat Options Oncol. 2012 Mar; 13(1):71-81.
    View in: PubMed
    Score: 0.379
  3. Targeting mTOR in Head and Neck Cancer-Response. Clin Cancer Res. 2019 11 01; 25(21):6555.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.